AdvanSix Inc

The asset is in a clear Stage 4 decline with downtrends across both long and short timeframes, and EMAs are acting as strong resistance. Mean reversion is not eligible, so we favor bearish medium-term bias, but oversold extension and extreme OS readings make immediate selling unfavorable. Instead, we will look to trim on tactical rallies into the declining EMAs and key resistance zones.

• ↑Q1 2026 revenue reached $404M, up 7% YoY on chemical intermediates volume growth.
• ↑Entering DEF market to meet growing EPA compliance demand and reduce import reliance.
• ↓Q1 2026 adjusted EBITDA tumbled to $5M, down $47M YoY, highlighting margin pressure.